July 2018—Becton Dickinson introduced several informatics and automation solutions for clinical laboratories at the European Congress of Clinical Microbiology and Infectious Diseases in Madrid, in April. The BD Synapsys microbiology informatics solution, which aims to help laboratories and hospitals meet cybersecurity and data privacy standards by providing secure connectivity across instruments and locations, will launch soon in the U.S. The solution will initially support BD Bactec FX systems, BD Kiestra solutions, and in the U.S., BD Veritor Plus systems.
The company aims to offer in mid-2019 in Western Europe its BD Cor system, a high-throughput, automated molecular platform designed to support a menu of clinically differentiated assays for women’s health, sexually transmitted infections, and gastrointestinal applications.
The BD Kiestra ID module will be offered in early 2019 and the ID/AST module will be available in mid-2019, initially in Europe and Canada, after regulatory authorizations are secured. BD Kiestra ID/AST modules automate the processing steps for bacterial identification and antibiotic susceptibility testing using the BD Bruker MALDI and BD Phoenix systems. These systems use a single organism to ensure the same bacteria is used in both tests.
The company also highlighted the CE-IVD-marked BD Max enteric viral panel, available in two configurations, for the identification of norovirus, rotavirus, adenovirus, sapovirus, and human astrovirus.
BD, +41 (0) 21 556 30 00